These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24978653)

  • 1. Atrial fibrillation and biomarkers of myocardial fibrosis in heart failure.
    Löfsjögård J; Persson H; Díez J; López B; González A; Edner M; Mejhert M; Kahan T
    Scand Cardiovasc J; 2014 Oct; 48(5):299-303. PubMed ID: 24978653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of collagen type I metabolism are related to B-type natriuretic peptide, left ventricular size, and diastolic function in heart failure.
    Löfsjögård J; Kahan T; Díez J; López B; González A; Edner M; Henriksson P; Mejhert M; Persson H
    J Cardiovasc Med (Hagerstown); 2014 Jun; 15(6):463-9. PubMed ID: 24983265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of Collagen Carboxy-Terminal Propeptide and Telopeptide to Predict Disturbances of Long-Term Mortality in Patients ≥60 Years With Heart Failure and Reduced Ejection Fraction.
    Löfsjögård J; Kahan T; Díez J; López B; González A; Ravassa S; Mejhert M; Edner M; Persson H
    Am J Cardiol; 2017 Jun; 119(12):2042-2048. PubMed ID: 28464988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating collagen metabolites, myocardial fibrosis and heart failure in aortic valve stenosis.
    Kupari M; Laine M; Turto H; Lommi J; Werkkala K
    J Heart Valve Dis; 2013 Mar; 22(2):166-76. PubMed ID: 23798204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.
    Ravassa S; Trippel T; Bach D; Bachran D; González A; López B; Wachter R; Hasenfuss G; Delles C; Dominiczak AF; Pieske B; Díez J; Edelmann F
    Eur J Heart Fail; 2018 Sep; 20(9):1290-1299. PubMed ID: 29709099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.
    Tziakas DN; Chalikias GK; Stakos D; Chatzikyriakou SV; Papazoglou D; Mitrousi K; Lantzouraki A; Thomaidi A; Boudoulas H; Konstantinides S
    Eur J Prev Cardiol; 2012 Feb; 19(1):62-71. PubMed ID: 20479644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen cross-linking but not collagen amount associates with elevated filling pressures in hypertensive patients with stage C heart failure: potential role of lysyl oxidase.
    López B; Querejeta R; González A; Larman M; Díez J
    Hypertension; 2012 Sep; 60(3):677-83. PubMed ID: 22824984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure.
    Plaksej R; Kosmala W; Frantz S; Herrmann S; Niemann M; Störk S; Wachter R; Angermann CE; Ertl G; Bijnens B; Weidemann F
    J Hypertens; 2009 Dec; 27(12):2483-91. PubMed ID: 19887955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinus rhythm restoration affects collagen turnover in patients with persistent atrial fibrillation.
    Kallergis EM; Goudis CA; Kanoupakis EM; Mavrakis HE; Maliaraki NE; Tzanakis N; Vardas PE
    Europace; 2014 Dec; 16(12):1726-30. PubMed ID: 25142742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure.
    López B; Ravassa S; González A; Zubillaga E; Bonavila C; Bergés M; Echegaray K; Beaumont J; Moreno MU; San José G; Larman M; Querejeta R; Díez J
    J Am Coll Cardiol; 2016 Jan; 67(3):251-60. PubMed ID: 26796388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover.
    Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Arfanakis DA; Maliaraki NE; Lathourakis CE; Chlouverakis GI; Vardas PE
    J Am Coll Cardiol; 2008 Jul; 52(3):211-5. PubMed ID: 18617070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating biomarkers of collagen type I metabolism mark the right ventricular fibrosis and adverse markers of clinical outcome in adults with repaired tetralogy of Fallot.
    Chen CA; Tseng WY; Wang JK; Chen SY; Ni YH; Huang KC; Ho YL; Chang CI; Chiu IS; Su MY; Yu HY; Lin MT; Lu CW; Wu MH
    Int J Cardiol; 2013 Sep; 167(6):2963-8. PubMed ID: 22999338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic peptides and right atrial fibrosis in patients with paroxysmal versus persistent atrial fibrillation.
    Cao H; Xue L; Wu Y; Ma H; Chen L; Wang X; Zhu Q; Dai N; Chen Y
    Peptides; 2010 Aug; 31(8):1531-9. PubMed ID: 20434499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction.
    Barthélémy O; Beygui F; Vicaut E; Rouanet S; Van Belle E; Baulac C; Degrandsart A; Dallongeville J; Montalescot G;
    Am J Cardiol; 2009 Oct; 104(7):904-9. PubMed ID: 19766754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation.
    Ravassa S; Ballesteros G; López B; Ramos P; Bragard J; González A; Moreno MU; Querejeta R; Vives E; García-Bolao I; Díez J
    J Am Coll Cardiol; 2019 Apr; 73(12):1398-1410. PubMed ID: 30922470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation.
    Tziakas DN; Chalikias GK; Papanas N; Stakos DA; Chatzikyriakou SV; Maltezos E
    Europace; 2007 Aug; 9(8):589-96. PubMed ID: 17485436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in NT-proBNP levels in patients with atrial fibrillation related to heart failure].
    Pokorná V; Jurkovicová O; Kaluzay J; Stecová A; Pont'uch P
    Vnitr Lek; 2010 Aug; 56(8):788-94. PubMed ID: 20845610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
    Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
    Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome.
    Ravassa S; López B; Querejeta R; Echegaray K; San José G; Moreno MU; Beaumont FJ; González A; Díez J
    J Hypertens; 2017 Apr; 35(4):853-861. PubMed ID: 28253222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of collagen type I turnover on the long-term response to cardiac resynchronization therapy.
    García-Bolao I; López B; Macías A; Gavira JJ; Azcárate P; Díez J
    Eur Heart J; 2008 Apr; 29(7):898-906. PubMed ID: 18334474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.